Provided by Tiger Trade Technology Pte. Ltd.

Merck

121.86
+0.20000.16%
Post-market: 122.000.1401+0.11%17:36 EST
Volume:8.92M
Turnover:1.08B
Market Cap:302.46B
PE:16.74
High:122.60
Open:121.40
Low:120.50
Close:121.66
52wk High:123.33
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.86
T/O Rate:0.36%
Dividend:3.28
Dividend Rate:2.69%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:37.17%
ROA:13.76%
PB:5.83
PE(LYR):16.74

Loading ...

Merck initiated with an Overweight at Barclays

TIPRANKS
·
1 hour ago

Is It Too Late To Consider Merck (MRK) After Its Strong Multi Year Share Price Run?

Simply Wall St.
·
4 hours ago

Merck Says New Phase 3 Data Indicate Stable Safety Profile for Enflonsia

MT Newswires Live
·
Yesterday

Merck announces new Enflonsia data from SMART trial

TIPRANKS
·
Yesterday

Merck reports positive Phase 3 SMART trial data for ENFLONSIA in high-risk children under 2 across two RSV seasons

Reuters
·
Yesterday

Merck & Co Inc - Smart Trial Data Shows Consistent Safety for Enflonsia

THOMSON REUTERS
·
Yesterday

Merck Announces Positive New Data for Enflonsia™ (Clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (Rsv) Disease Over Two Rsv Seasons

THOMSON REUTERS
·
Yesterday

Merck, Mayo Clinic announce new R&D collaboration

TIPRANKS
·
Feb 18

Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine

THOMSON REUTERS
·
Feb 18

Merck and Mayo Clinic Form AI-Driven Drug Discovery Collaboration

Reuters
·
Feb 18

EXCLUSIVE-California preparing lawsuit over Trump administration vaccine changes

Reuters
·
Feb 18

Top News Today/Canada: Inflation Cooled a Bit in January

Dow Jones
·
Feb 18

Merck announces Health Canada approval of KEYTRUDA SC

TIPRANKS
·
Feb 18

BRIEF-Mubadala Investment Co Pjsc Reports Share Stake In Pfizer, Abbvie, Dissolves in Merck, Dell

Reuters
·
Feb 18

Health Canada Approves Merck's Subcutaneous KEYTRUDA for Multiple Cancers

Reuters
·
Feb 18

Health Canada Approves Keytruda Sc™, a Subcutaneous Formulation of Pembrolizumab Across Multiple Cancer Indications

THOMSON REUTERS
·
Feb 18

Is Merck’s First PD-1 Ovarian Cancer Approval Reshaping The Investment Case For Merck (MRK)?

Simply Wall St.
·
Feb 17

REFILE-Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees

Reuters
·
Feb 16

A Look At Merck (MRK) Valuation After New Keytruda Approval And Oncology Data Updates

Simply Wall St.
·
Feb 15

ECOB, Delta, Merck, Carnival, RTX Insiders Cash Out

TIPRANKS
·
Feb 14